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To cvaluatc the involvomcnr of protein phosphatascs (PP! in dilTcrcntintion of human myclogcnous lcukamia HL-60 cclls, wo mada use ofpotcnt 
inhibitors of PPl and PP2A, calyculln-A (CAL-A) and okadaic acid (OKA). CAL-A and OKA could augment all-rmns rctinoic acid (ATRA). 
induced granulocytic difficrcntiation, whcrcas the diffcrentintion toward mncrophagc lincngc by 12+tctmdccanoylphorbol acctatc (TPA) was 
unchanged in the 7rcscncc of CAL-A. CAL-A nugmcntcd the phosphorylation of ISK, 23K and 30K protein% induced by ATRA. The PPt and 
PP2A wcrc idcntificd and wcrc present mainly in the cytosol of HL-60 cells. Thcsc results uggest that cithcr PPl or PP2A or both may bc inv&& 
in regulating ranulocytic diffcrcntiation of HL-60 cells. 
HL-60 cell: DilWcntiation: Phosphatasc; Ohadaic Acid; Calyculin-A 
1. INTRODUCTION 
Human myclogenous HL-60 leukemia cells can be 
induced to differentiate into either monocytelmacro- 
phage-like cells or into granulocytes by various chemi- 
cal agents [l-4]. These include 1,25_dihydrovitamin DS 
and 12-o-tetradecanoyl-phorbol-1Iacetate (TPA), 
which mediate monocytic differentiation, and all-truns 
retinoic acid (ATRA) and dimethylsulfoxide for gran- 
ulocytic differentiation. Some protein kinases have been 
identified as molecules comprising cellular signal 
transduction etworks and it has become apparent hat 
the regulated expression of protein kinases is crucial as 
mediator of differentiation signals [5-IO]. The regula- 
tion of protein function by phosph?rylation requires 
protein phosphatases in addition to protein kinascs. It 
is therefore conceivable that phosphatase activity PXI~ 
influence mechanisms underlying ceil differentiation. 
There appear to be four ti&dominant forms, designated 
as PPI, PPZA, PP2B and PPZC by the classification 
system proposed by Ingebristen and Cohen [l l]. To 
clarify the role of PPI and PP2A, two of four serinc- 
threonine-specific protein phosphatases, inthe leukemic 
ccl1 differentiation, we used two types of potent phos- 
phatase inhibitors, OKA [12] and CAL-A [13,14] as 
probes for biological processes controlled by phospho- 
rylation. These compounds are cell-permeable, and they 
inhibit PPI and PP2A without affiting other 
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phosphatases or a variety of protein kinases including 
protein kinase C [12-151. We also identified and quanti- 
tated PP1 and PPZA in HL-60 cells using the procedures 
[16] based on the use of OKA in conjunction with inhib- 
itor-2 and immunological analysis using specific anti- 
bodies to PP1 and PP2A. 
2. MATERIALS AND METHODS 
1.1. Reagents 
CAL-A and OKA wcm pumhascd from Wake “urc Chemical In- 
dusttics. Ltd. (Osaka, Japan). ATRA was purchased from Sigma (St. 
Louis, MO). Heat-stable phosphatasc inhibitor-2 ws purified accord- 
ing to the pnxdure of Yang ct al. [17). 
The cxtcnt of diffcrcntiation was cxrmincd by the morphological 
asscssmcnt, ability of nitmbluc tctrazolium {p!PT. I’;sn;?; xducaiqn 
and surface tuar?xr analysi; as dexribed [8-!OJ l*,Shcsion cd> cr;;l- 
incd by quantitating cells that adhered to the culture disn [8]. 
2.3. Ire viva phosphorytation of cellular protein 
The lab&d cells were exposed to nxgcnts and analyzed by two- 
dimensional is~lctcctrofocusindpolyacrylamidc gels, as described PI. 
2.4. Pqxnnrion of protein phosphates. and etqme assa) 
The HL-60 cclts (I x 10’ cells~ were homogenized in but& A (20 
mM Tris-WI. pH 7.4, 2 mM dithiothrcitol. 2 mM BGTA. 2 mM 
EDTA, and a cocktail of protcase inhibitors) containing 0.25 M su- 
cmsc by a glass-to-glass Potter-Elvettjcm homogcnizcr. The homoge- 
nate was immcdiatcly ccntriflrged at 1,000 X g for 10 min to sparate 
the crude nuclcnr faction. The supcrnatant was then ultracentrifuged 
at 100,000 x g for 1 h to scpamte the cytosol and plasma membrane 
Fixction. The cytosolic faction of HL-60 cells was treated by freezing 
and thawing in the prcscncc of 0.2 M 2-mcrcaptocthanol. and was 
applied to ic column (1.5 x 5.7 cm) of hcparinScpharose CL-68 cquili- 
brated with buffer A [S. 181. The column was cxtcnsivcly washed with 
PttbIished by Elsevier Science Publishers B. K 
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Fig. 1. Effects of CAL-A or OKA on dill’crcnriation of HL-60 cells 
induced by ATRA. Dosc-dcpcndcnt cfkcts of CAL-A (A) or OKA (13) 
on the ditl’crcntiation of HL-60 cells induced by 1 FM ATRA. Phos- 
phatasc inhibitors wcrc added 1 h prior to stimulation with dillkcnti- 
ating inducing agents. Diffcrcntiation was dctcrmincd by NBT rcduc- 
tion test after a 72 h incubation. Data replrscnt he mean + SD. Tom 
three scparar cxprimcnts. 
buffer A and clutcd batchwisc with buffer A containing 0.5 M NaCI. 
Phosphatase activity was dctcrmincd by the liberation Of “Pi from the 
substrate (S”P-labclkd myosin light chain) at 30°C according to the 
methods of Pato and Kcrc 1191. 
2.5. Preparation of anlibodics against PPI and PPA4. ttnditnnttutobfor 
ana~vsis 
Protein from the fraction with a peak ;hosphatasc activity was 
analyzed by immunoblot [lo] using rabbit polyclonal a&bodies spc- 
cific for PP1 [20] and PPZA [2l]. 
Table 1 
Morphological changes of HL-60 cells aflcr incubation with 1 pM 
ATRA in the prcscncc or abwncc of 1 nM CAL-A for 4 days 
Mycloid ccl& % of total cells 
Mybl. Promy. Myclo. Mcta. Band.. Scg. 
Control fl 88.5 8.5 1.0 0 0 
ATRA (1 pM) 1.5 19.5 62.0 13.0 3.5 
ATRA (1 @I) + 
CAL-A (1 nM) 0 0 4.5 46.0 42.5 7.0 
HL-60 ccll$ WIXC incubated in conditions indicated. DifIkcn~ial 
counts wcrc,pcrl’ortncd on May-Grilnwald-Gicm#a stain& cytospin 
pmparations of the orI1 subpensions alter 4 days incubation. Results 
Ram a rcprcscntalive dctcrmination are shown. In each case, a mini- 
mum of 200 cells wcrc scored. Mybl., myctoblasl; Promy., promyclo_ 
cytc; Mycto.. myclocytc; MC% mctamyclocyw Band., banded ncu= 
trophil; Sq.. sqmcntcd ncutroph&i. 
3. RESULTS 
3.1. Effect ofCAL-A and OKA on ATRA-inducedgm- 
utocytic and WA-induced ntacmphtage lkwge di(- 
ferentiation iir HL# cells 
CAL-A at concentrations of 1 nM or lower had no 
efkct on proliferation. CAL-A alone induced no diRr- 
entiation. ATRA suppressed the proliferation of HL-60 
cells and induced HL-60 cells to differentiate terminally 
into granulocytes. The addition of CAL-A in combii- 
tion with ATRA led to further maturation, when com- 
pared to findings with ATRA alone (Table 1). The re- 
duction of NBT provides a functional marker for gran- 
ulocytic differentiation of HL-60 cells. The combination 
of CAL-A and ATRA resulted in a fuqher increase in 
the number of NBT-positive celb (Fii. IA). CAL-A 
alone induced no increase in the number of NBT-posi- 
tive cells. The enhancement of ATRA-induced difTe=n- 
tiation monitored by NBT reducat~n occur~~I in a &sp 
dependent manner in concentrations from 0.1 nM to 1.0 
nM of CAL-A (Fip ! .4;. OKA. aa&kr yhq91atase 
Table II 
Adhesion rate and expression of surface membrane antigens of HL-60 cells during differentiation induced by ATRA or WA in rhe presenoz r
abscncc of 1 nM CAL-A 
Control ATRA ATRA + CAL-A I-PA I-PA + CAL-A 
(1 W) (1 PM) (t nM) (2 nhf) (2 nhl) (1 nhi) 
Adhesion (%) 0 0 0 43.8 + 2.4 44.1 + 3.1 
CD1 lb 0.1 78.2 90.3 48.5 50.4 
CD1 lc 0 28.4 60.8 49.6 49.4 
CDS4 
CD71 Z.6 
95.4 96.8 98.7 99.0 
13.0 6,l 83.0 81.2 
In ATRA-induced diffcrcntiation, HL-60 cells were cultured for 84 h under the condition indicated and analyzed for antibody binding by flow 
cytomcuy. In TPA induced differentiation, to assess the adherence ram, HL-60 ~~11s wcw pretrcaccd with or without 1 nM CAL-A for 6 h and 
then dulturni with 5 nM TPA for 24 h. Results represent the mean i SD. from three experiments. In surl’xv marker analysis, thecells were cultured 
with 2 nM TPA for 1s h after pretreatment with or without 1 nM CAL-A For 6 h. Values rcpmnt the means of duplicate xpcrimcnc and are 
expmsed as the prxntagc of positive cells. Standard deviations were less than 10%. 
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Fig. 2. &ffccts of CAL-A on phospborylation of cellular proteins in HL-60 cells. I-iL-60 cells were incubated with 3*P, for 1 h tit 37°C and then 
exposed to 10pM RA or/and 10 nM CAL-A for an additional 30 min. TIE cells were lyzcd and the whole ccl1 proteins analyzed by two-dimensional 
gel elcctrophorcsis and autoradiography. Designations of proteins (indicated by arrows) with increased phosphorylation ivvere made after consistent 
observation in two or more expcrimcnts. A representative experiment is shown. A, control; B, 10 ,uM ATRA; C, IO nM CAL-A; D, 1OpM ATRA 
plus IO nM CAL-A; kDa, molecular weight in thousands. 
inhibitor, also enhanced ATRA-induced differentiation 
dose-dependently in the concentration range of 20-80 
nM (Fig. 1B). Table II shows the flow cytometric assess- 
rnent of enhanced ATRA-induced granulocytic differ- 
eatiation in the presence of CAL-A. The percentage of 
surface antigens detected by monoclonal antibodies 
CD1 lb (OKMl), CD1 lc (LeuMS) and CDS4 (anti- 
1CAM) increased and that of CD71 (OKT9) decreased 
together with the maturation by 1 yM ATRA. These 
changes in s~~J+~~+ n?arlrprs >>!ere consistent with di,ffer- “..M_” . ..“...W. 
entiation to more mature granulocytes. This modula- 
tion of surface antigen expression was significantly en- 
hanced in the presence of CAL-A. Effects of CAL-A on 
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TPA-induced differentiation of HL-60 cells into macro- 
phage-like cells were also examined by differentiation 
parameters uch as adhesion rate and surface markers 
(Table II). CAL-A did not affect the differentiation into 
macrophages. 
3.2. Stimrlution ofprotein pllos~lto~ylrrtiort in intact HL.- 
GO cells by R.4 cd/or CAL-A 
ATRA treatment increased the phosphorylation of 
3OK, 23K and 1% Proteins compared with the control 
(Fig. 2). CAL-A by itself enhanced the phosphorylation 
of several distinct proteins (molecular mass = 30K, 
XK, 23K, 20K, 1X). The extent of increased phospho- 






Fig. 3. Chromatography of the phosphatase activity of the cytosol from l-IL-60 cells on hcparin-Scpharase CL-6B. Proteins from cytosol fraclions 
of HL-60 cells were applied to a heparin-Scpbarosc column equilibrated with buffer A. Column was eluted with buffer A switohing IO buffer A 
containing 0.5 M NaCl where indicated. Phosphatasc activity (a-) was measured using phosphorylated myosin light chain as substrate, and 
absorbance (-) was measured at 280 nm. lmmunoblot analysis of phosphatase in the cytosol f HL-60 cells is hown in the insert. A sample (1Opl) 
of peak phosphatase fractions from heparin-ticpharosc chromatography was subjected to immunoblot analysis using antibodies pecific for PPl 
and PPZA. 
rylation in response to the combination of CAL-A and 
ATRA indicated that the effect of both ATRA and 
CAL-A may be additive. 
3.3. Activity of protein serhdtlwcorrirze plmphatmes ill 
HL-60 cells 
We employed “P-phosphorylated myosin light chain 
as a substrate of phosphatase assay, because it is a good 
substrate for both mammalian PPl and PP2A. Analysis 
of subcellular distribution of phosphatase activity from 
crude extracts of HL-60 ceils revealed that phosphatase 
is distributed in various locations with the largest activ- 
ity present in the cytosol. Relative activities of cytosol, 
plasma membrane and nuclear fractions were approxi- 
mately 59%, 16% and 25%, respectively. After the HL- 
60 cytosolic fraction had been treated by freezing and 
thawing in the presence of 0.2 M 2-mercaptocthanol to 
convert from holocnzyme to a free catalytic subunit, it 
was adsorbed onto a heparin-Sepharose column (bed 
volume = 10 cm”) and then eluted batch-wise with 0.5 M 
NaCl (Fig. 3). lmmunoblot analysis (Inset of Fig. 3) 
revealed that peak fractions eluted at 0.5 M NaCl con- 
tained both PPl and PP2A. OKA and CAL-A inhibited 
this peak activity dose-dependently with ICsO values of 
2.5 nM and 4.2 nM, respectively. The use of a combina- 
tion of OKA and inhibitor-2 allows PPl and PP2A to 
be quantitated in two independent ways 1161. PP2A is 
inhibited completely by 2 nM OKA; in contrast, PPI is 
hardly affected at this concentration, complete inhibi- 
tion requirirrg 1 PM. On the other hand, more than 90% 
of PPl is inhibited by inhibitor-2 after 15 min preincu- 
bation. PPl can be taken as the activity which is sensi- 
tive to the inhibitor-2 and PP2A can be taken as the 
activity which is blocked by 2 nM OKA. Based on this 
simple procedure, the proportion of PPl relative to 
PP2A was estimated to be almost its equivalent (Fig. 4). 
4. DISCUSSION 
Serine/threonine protein phosphatase inhibitor, 
CAL-A did augment the differentiation toward gran- 
ulocytcs by ATRA of l-IL-60 cells as evidenced by al- 
tered morphology, expression of differential surface 
markers and NBT reduction ability. CAL-A by itself, 
however, did not directly affect the differentiation. In 
contrast, CAL-A had no effect on differentiation into 
macrophages by TPA. CAL-A enhanced the protein 
phosphorylation of l-IL-60 cells induced by ATRA. 
CAL-A by itself stimu!ated the phosphorylation of 
some proteins (30K, 26K, 23K, 20K, 18K) in HL-60 
cells. Moreover, CAL-A augmented ATRA-induced 
phosphorylation of 30K, 23K and 18K proteins. These 
results imply that in addition to basal protein kinase 
activities, protein phosphatases are active and prevent 
the accumulation of phosphorylated proteins in unstim- 
ulated HL-60 cells. One or more of these increased 
phospboproteins may be the target factor(s) responsible 
for augmented ifferentiatien toward granulocytes. The 
23K protein phosphorylation seemed to be specific to 
granulocytic differentiation since it was not detected in 
TPA-induced differentiation [7], although the nature 
and subcellular localization of this protein are un- 
known. The precise mechanism by which ATRA exerts 
its biologic effects is unclear. ATRA is thought to elicit 
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Fig. 4. Inhibition of phosphatasc activity from a cytosolic fraction of 
HL-60 cells by OKA (2 nM) and excess inhibitor-2 in vitro. Phosphat- 
asc which was partially purified by heparin-Sepharosc chromatogra- 
phy was also used. The enzyme mixture was preincubated with the 
indichtLd compounds 1.5 min prior to adding the substmte. Data are 
expressed as percent of control activity and rcprcscnt the mean f S.D. 
from three experiments. 
its effects by binding to nuclear RA receptor (RAR) 
belonging to an e&A-related steroid/thyroid receptor 
family and the ATRA-RAR complex is thought to reg- 
ulate the transcription of target genes [223. Our results 
suggest hat protein phosphorylation is partly involved 
in intracellular events that may initiate the process lead- 
ing to cessation of proliferation and to terminal differ- 
entiation of the HL-60 cells subsequent to ATRA-RAR 
interaction. The identification of these enhanced 
phosphoproteins will be of a great importance in under- 
standing the cellular differentiation mechanism. Thus, 
CAL-A-sensitive protein phosphatases may be, at least 
in part, involved as negative regulators of the signal 
transduction in ATRA-induced granulocytic differenti- 
ation. 
We also identified and quantitated CAL-A-sensitive 
protein phosghatases, PPl and PP2A, in the cytosol of 
HL-60 cells by the procedure based on the use of OKA 
and inhibitor-2 and immunological analysis using spe- 
cific antibodies to PPl and PP2A. The varying ICsO 
values for PPl and PP2A allow OKA to be used to 
distinguish between these activities in cell-free systems, 
but in whole cells complication can arise in differentiat- 
ing between the effect of OKA on PPl and PPZA. 
Therefore, it is not possible to conclude whether PPl or 
PP2A or both are relevant to signal transduction of 
ATRA-induced differentiation processes at present. 
Further studies are necessary to characterize these 
phosphatases of HL-60 cells in more detail, including 
the purification, substrate specificities and regulatory 
mechanisms. 
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